Quick Answer
PAVmed Inc. reported Cash And Cash Equivalents At Carrying Value of $1.54 million for the year ending 2025.
- PAVmed Inc. showed an increase of +29.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PAVmed Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $521.6 thousand | Q3 2015: $1.42 million | Q1 2016: $236.1 thousand | Q2 2016: $3.02 million | Q3 2016: $1.79 million | Q1 2017: $905.7 thousand | Q2 2017: $82.1 thousand | Q3 2017: $3.11 million | Q4 2017: $1.54 million | Q1 2018: $3.63 million | Q2 2018: $11.14 million | Q3 2018: $9.24 million | Q1 2019: $4.19 million | Q2 2019: $6.91 million | Q3 2019: $4.10 million | Q1 2020: $8.73 million | Q2 2020: $7.08 million | Q3 2020: $8.29 million | Q1 2021: $48.55 million | Q2 2021: $43.21 million | Q3 2021: $37.34 million | Q1 2022: $64.74 million | Q2 2022: $65.15 million | Q3 2022: $56.79 million | Q1 2023: $49.28 million | Q2 2023: $37.16 million | Q3 2023: $26.41 million | Q1 2024: $25.54 million | Q2 2024: $25.50 million | Q3 2024: $765.0 thousand.
- Over the full 12 years of available data (2014 to 2025), PAVmed Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 83.3%.
- Historical annual values: Fiscal year 2025: $1.54 million | Fiscal year 2024: $1.19 million | Fiscal year 2023: $19.64 million | Fiscal year 2022: $39.74 million | Fiscal year 2021: $77.26 million | Fiscal year 2020: $17.26 million | Fiscal year 2019: $6.22 million | Fiscal year 2018: $8.22 million | Fiscal year 2017: $1.54 million | Fiscal year 2016: $585.7 thousand | Fiscal year 2015: $767.3 thousand | Fiscal year 2014: $839.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: